Theravance holds ampreloxetine KOL event; AGM set for June 12, 2026

Theravance Biopharma, Inc.

Virtual KOL investor event for ampreloxetine held Dec. 8, 2025; slide deck furnished as exhibit.
2026 Annual General Meeting scheduled for June 12, 2026 in Dublin, Ireland.
Proxy materials will be filed with SEC and made available to shareholders prior to the meeting.

item 8.01 item 9.01

Theravance Biopharma, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-25-119032

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.